BR9810280A - Pós de prolipossomo para inalação estabelizada por tocoferol. - Google Patents

Pós de prolipossomo para inalação estabelizada por tocoferol.

Info

Publication number
BR9810280A
BR9810280A BR9810280-0A BR9810280A BR9810280A BR 9810280 A BR9810280 A BR 9810280A BR 9810280 A BR9810280 A BR 9810280A BR 9810280 A BR9810280 A BR 9810280A
Authority
BR
Brazil
Prior art keywords
tocopherol
inhalation
established
powder
proliposome
Prior art date
Application number
BR9810280-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9810280A publication Critical patent/BR9810280A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9810280-0A 1997-06-27 1998-06-08 Pós de prolipossomo para inalação estabelizada por tocoferol. BR9810280A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (fr) 1997-06-27 1998-06-08 Poudres de proliposomes stabilisees par tocopherol et destinees a l'inhalation

Publications (1)

Publication Number Publication Date
BR9810280A true BR9810280A (pt) 2000-09-12

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810280-0A BR9810280A (pt) 1997-06-27 1998-06-08 Pós de prolipossomo para inalação estabelizada por tocoferol.

Country Status (18)

Country Link
EP (1) EP1001749A1 (fr)
JP (1) JP2002510311A (fr)
KR (1) KR20010014163A (fr)
CN (1) CN1260713A (fr)
AU (1) AU729100B2 (fr)
BR (1) BR9810280A (fr)
CA (1) CA2295028A1 (fr)
EE (1) EE9900601A (fr)
HU (1) HUP0003207A3 (fr)
ID (1) ID23192A (fr)
IL (1) IL133478A0 (fr)
IS (1) IS5304A (fr)
NO (1) NO996439L (fr)
NZ (1) NZ501672A (fr)
PL (1) PL337723A1 (fr)
SK (1) SK184899A3 (fr)
TR (1) TR199903271T2 (fr)
WO (1) WO1999000111A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
MX2007015577A (es) * 2005-06-09 2008-02-25 Biolipox Ab Metodo y composiciones para el tratamiento de trastornos inflamatorios.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2014180827A1 (fr) * 2013-05-06 2014-11-13 Dsm Ip Assets B. V. Formulation en poudre de vitamine e
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081474A1 (fr) * 1990-05-08 1991-11-09 Manzer Durrani Methode de sechage par pulverisation directe de solutions de lipides et de medicaments solubles dans l'eau
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
CA2295028A1 (fr) 1999-01-07
HUP0003207A3 (en) 2001-03-28
KR20010014163A (ko) 2001-02-26
IS5304A (is) 1999-12-15
HUP0003207A2 (hu) 2001-02-28
WO1999000111A1 (fr) 1999-01-07
AU7945698A (en) 1999-01-19
ID23192A (id) 2000-03-23
AU729100B2 (en) 2001-01-25
JP2002510311A (ja) 2002-04-02
SK184899A3 (en) 2000-05-16
TR199903271T2 (en) 2000-08-21
EP1001749A1 (fr) 2000-05-24
NO996439D0 (no) 1999-12-23
PL337723A1 (en) 2000-08-28
EE9900601A (et) 2000-08-15
NO996439L (no) 2000-02-28
IL133478A0 (en) 2001-04-30
NZ501672A (en) 2001-06-29
CN1260713A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
BR9810280A (pt) Pós de prolipossomo para inalação estabelizada por tocoferol.
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
MY114114A (en) Process for the preparation of powders for inhalation and powders obtainable thereby
DK440386D0 (da) Laegemiddelholdigt chlorfluorcarbon-aerosoldrivmiddelpraeparat
BR9703624A (pt) Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem
BR9916587A (pt) Aparelho e processo para preparar partìculas cristalinas de uma substância, população de partìculas, composição farmacêutica e partìculas cristalinas de 2,6-diamino-3-(2,3,5-triclorofenil)-pirazina
BR9809328A (pt) Processo para preparação de formas sólidas de medicamentos empregáveis peroralmente com desprendimento controlado de substância ativa
FR2784296B1 (fr) Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
BR9609447A (pt) Composto formulação farmacêutica uso de um composto e processos para preparação de um composto e tratamento de uma condição em que é necessária trombina
AU4151099A (en) Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same
BR9712125A (pt) Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
CA2216320A1 (fr) Emulsions stables et poudres seches de melanges de vitamines liposolubles, leur preparation et leur utilisation
IL105944A (en) Phospholipid-containing cosmetic preparation and its production
ES2090712T3 (es) Medicamento agudo que contiene ibuprofeno y su uso.
BR9914800A (pt) Preparação e uso de óleos solidificados
SE8800080D0 (sv) Lekemedelskomposition
ATE235219T1 (de) Kosmetische zubereitungen
ES2181054T3 (es) Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.
ATE234319T1 (de) Glykosylierte-ginkgolid-derivate, ihre verwendung als arzneimitteln und pharmazeutische zubereitungen die sie enthalten
BR9812120A (pt) Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação
DE69711588D1 (de) Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung
ATE150305T1 (de) Therapeutische anwendung von histamin-h3- agonisten, neue wirkstoffe und verwendung zur herstellung von arzneimitteln
ES2183534T3 (es) Agentes cosmeticos o farmaceutios que contienen acidos ribonucleicos o acidos desoxirribonucleicos.
HRP960076B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds, as well as medicaments containing them
BR9911378A (pt) Processo para fabricar um pó antiperspirante.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9AANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.